Medigene Management
Management criteria checks 4/4
Medigene's CEO is Selwyn Ho, appointed in Jul 2022, has a tenure of 2.33 years. total yearly compensation is €445.00K, comprised of 80.9% salary and 19.1% bonuses, including company stock and options. directly owns 0.42% of the company’s shares, worth $107.60K. The average tenure of the management team and the board of directors is 2 years and 7.3 years respectively.
Key information
Selwyn Ho
Chief executive officer
€445.0k
Total compensation
| CEO salary percentage | 80.9% |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.4% |
| Management average tenure | 2yrs |
| Board average tenure | 7.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -€16m |
| Mar 31 2024 | n/a | n/a | -€16m |
| Dec 31 2023 | €445k | €360k | -€16m |
| Sep 30 2023 | n/a | n/a | -€23m |
| Jun 30 2023 | n/a | n/a | -€29m |
| Mar 31 2023 | n/a | n/a | -€19m |
| Dec 31 2022 | €612k | €157k | -€8m |
Compensation vs Market: Selwyn's total compensation ($USD468.47K) is about average for companies of similar size in the US market ($USD651.40K).
Compensation vs Earnings: Selwyn's compensation has been consistent with company performance over the past year.
CEO
Selwyn Ho (53 yo)
2.3yrs
Tenure
€445,000
Compensation
Dr. Selwyn Ho, MBBS, serves as Chief Executive Officer & Chairman of the Executive Management Board at Medigene AG since July 25, 2022. He served as Chief Business Officer at Connect Biopharma Holdings Lim...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of Executive Management Board | 2.3yrs | €445.00k | 0.42% $ 107.6k | |
| Chief Scientific Officer | 10.5yrs | €486.00k | no data | |
| Co-Founder & Chairman Scientific Advisory Board | no data | €20.00k | no data | |
| Chief Financial Officer | no data | no data | no data | |
| Vice President of Investor Relations & Corporate Communications | 1.7yrs | no data | no data | |
| VP and Head of Clinical Research & Development | 1.7yrs | no data | no data |
2.0yrs
Average Tenure
Experienced Management: MDGE.F's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman Scientific Advisory Board | 7.3yrs | €20.00k | no data | |
| Independent Member of the Supervisory Board | 3.9yrs | €24.00k | no data | |
| Independent Deputy Chairwomen of the Supervisory Board | 8.3yrs | €38.00k | no data | |
| Independent Chairman of the Supervisory Board | 7.5yrs | €45.00k | no data | |
| Independent Member of the Supervisory Board | 7.5yrs | €26.00k | no data | |
| Independent Member of the Supervisory Board | 6.5yrs | €30.00k | 0.071% $ 18.3k | |
| Member of Scientific Advisory Board | 7.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 7.3yrs | no data | no data |
7.3yrs
Average Tenure
68yo
Average Age
Experienced Board: MDGE.F's board of directors are considered experienced (7.3 years average tenure).